| Patient | Bob Marley |
|---|---|
| Date of birth | 1994-02-06 |
| Identifiers | MRN HR-ML027-SYN; SSN (made up) 000-27-4065 |
| Document date | 2026-06-17 |
| Author | Desmond Clarke, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Toenail biopsy result and surgical oncology consultation. [S]
Mr. Marley returns nine days after his first visit. The clinic's dermatologist examined the nail with dermoscopy two days after that visit, found a band with irregular lines of varying color and spacing and pigment on the nail fold, and took a full-thickness excisional biopsy of the nail matrix under a digital block. The biopsy shows acral lentiginous melanoma, 0.8 mm thick, not ulcerated. The biopsy site has healed under the dressing; he has needed no pain medicine. He has no lumps in the groin or behind the knee, no cough, headache, or weight loss. Dr. Mbeki-Rowe of surgical oncology saw him this morning and went through the choices for surgery with him at length. He said that his faith, his music and his football all matter to him in this decision, and that he would like to keep the toe if that can be done without lowering his chance of cure. He has had no thoughts of self-harm. [S]
| Element | Detail |
|---|---|
| Diagnosis | Acral lentiginous melanoma of the right great toe nail unit, Breslow 0.8 mm, not ulcerated, mitotic rate 1 per mm2 |
| Clinical stage | IB (cT1b N0 M0); no symptoms of spread |
| Biopsy site | Healing; no pain medicine needed |
| Coordination | Surgical oncology seen this morning; surgery planned in two weeks |
| What matters to him | His faith, his music and his football; keeping the toe if that is safe |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No weight loss, fever, or night sweats |
| Respiratory | Negative | No cough or breathlessness |
| Neurological | Negative | No headache or weakness |
| Integumentary | Negative | No other new or changing spots, bands, or sores |
| Hematologic and lymphatic | Negative | No lumps in the groin or behind the knee |
| Psychiatric | Positive | Worried about the operation and touring; PHQ-9 4, GAD-7 6; no thoughts of self-harm |
6 systems reviewed. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-06-17 | Body height | 170 | cm | S |
| 2026-06-17 | Body weight | 66.2 | kg | S |
| 2026-06-17 | Body mass index (BMI) [Ratio] | 22.9 | kg/m2 | S |
| 2026-06-17 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-06-17 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-06-17 | Heart rate | 70 | /min | S |
| 2026-06-17 | Respiratory rate | 14 | /min | S |
| 2026-06-17 | Body temperature | 36.6 | Cel | S |
| 2026-06-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-06-17 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 2026-06-17 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 6 | {score} | S |
Vital signs recorded on 2026-06-17; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 124/78, pulse 70; weight 66.2 kg |
| Right great toe | Biopsy site healing over the proximal nail; the remaining nail plate shows the distal part of the brown-black band; pigment on the proximal nail fold; no nodule or ulcer |
| Lymph nodes | No right popliteal or inguinal nodes; no left inguinal, axillary, or cervical nodes |
| Skin and nails | Whole skin examined, including the scalp, palms, soles, between the toes, and all nails: no other suspicious lesion |
| Abdomen | Soft; liver not enlarged |
| Psychiatric | Calm, thoughtful; asks careful questions |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| A brown-black band in the right great toenail, about 5 mm wide (about a third of the nail), with irregular dark lines, first noticed about two months ago after a knock at football and not growing out with the nail; the pigment extends onto the skin of the proximal nail fold (Hutchinson sign). Suspected subungual melanoma; dermoscopy and a full-thickness nail matrix biopsy booked this week | resolved | confirmed | L60.8 | S — Synthetic presenting problem linked to his documented toe lesion; superseded by the diagnosis at the surgical oncology consultation. |
| Acral lentiginous melanoma of the nail unit (subungual) of the right great toe, on full-thickness nail matrix biopsy: Breslow thickness 0.8 mm, not ulcerated, mitotic rate 1 per mm2, no lymphovascular or perineural invasion; clinical stage IB (cT1b N0 M0); synthetic modern detail linked to his documented acral lentiginous melanoma | active | confirmed | C43.71 | S — Synthetic thickness and stage; the site, the subtype, and the year are documented (D). |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | Biopsy pathology: Breslow thickness, ulceration, mitotic rate, margins, and microsatellites | At diagnosis | Up to date | 0.8 mm, not ulcerated, mitotic rate 1 per mm2, no lymphovascular or perineural invasion, no microsatellites; melanoma in situ at the lateral edges |
| Examination | Dermoscopy of the nail | At presentation with a pigmented nail band | Up to date | By the dermatologist two days after the first visit: irregular lines and pigment on the nail fold |
| Examination | Full skin and nail examination, including the scalp, palms, soles, between the toes, and all nails | At diagnosis, then at each surveillance visit | Deferred | A deviation: the dermatologist examined the hands, feet and nails at the biopsy visit, but a full skin examination at diagnosis was not recorded. Dr. Clarke examined the whole skin today and found no other suspicious lesion, so no harm resulted. Corrective action: a yearly full skin examination by dermatology is booked, and the full examination is part of each surveillance visit |
| Examination | Examination of the lymph node basins (right popliteal and inguinal) and the scar | At diagnosis, then at each surveillance visit | Completed today | No palpable nodes |
| Imaging | Imaging (CT, PET, or ultrasound) and LDH | Not routine for stage I to II without symptoms | Not indicated | Clinical stage IB without symptoms; scans and LDH would not change management |
| Referral | Sentinel lymph node biopsy | Discussed and offered for T1b melanoma | Ordered | Accepted; with the excision in two weeks, after lymphoscintigraphy |
| Referral | Surgical oncology | At diagnosis of invasive melanoma | Completed today | Seen this morning; recommendations in the consultation note |
| Self-management | Shared decision on the extent of surgery | Before definitive surgery | Completed today | Amputation and digit-sparing excision explained with their outcomes; he chose digit-sparing excision; written summary given |
| Laboratory | Germline genetic testing | Only with several primary melanomas or a strong family history of melanoma or pancreatic cancer | Not indicated | A single primary melanoma; no criterion met |
| Survey | Distress and depression screen (PHQ-9) | At diagnosis | Completed today | PHQ-9 4 and GAD-7 6; no thoughts of self-harm |
Goal progress:
Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Melanoma: Cutaneous, Version 3.2026 (2026); Swetter SM, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol 2019;80(1):208-250 (2019); Gershenwald JE, et al. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 2017;67(6):472-492 (2017); Wong SL, et al. Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update. J Clin Oncol 2018;36(4):399-413 (2018); Chouquet L, et al. Reconstruction After Wide Excision of the Nail Apparatus in the Treatment of Melanoma: A Systematic Literature Review. J Clin Med 2025;14(17):5932 (2025); Depression and Suicide Risk in Adults: Screening (2023)
Follow-up: Surgery in two weeks with Dr. Mbeki-Rowe. Review two weeks after surgery with the final pathology. Call for a lump in the groin, or for redness or discharge at the biopsy site. Next scheduled visit 2026-07-15: review two weeks after digit-sparing excision and sentinel node biopsy: final pathology and stage, graft care, and the surveillance plan. [S]